Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing disulfides that drive the production of critically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback